226 related articles for article (PubMed ID: 12743174)
21. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells.
Mihaylova VT; Bindra RS; Yuan J; Campisi D; Narayanan L; Jensen R; Giordano F; Johnson RS; Rockwell S; Glazer PM
Mol Cell Biol; 2003 May; 23(9):3265-73. PubMed ID: 12697826
[TBL] [Abstract][Full Text] [Related]
22. Different mismatch repair deficiencies all have the same effects on somatic hypermutation: intact primary mechanism accompanied by secondary modifications.
Kim N; Bozek G; Lo JC; Storb U
J Exp Med; 1999 Jul; 190(1):21-30. PubMed ID: 10429667
[TBL] [Abstract][Full Text] [Related]
23. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
24. Hypermutation in Ig V genes from mice deficient in the MLH1 mismatch repair protein.
Phung QH; Winter DB; Alrefai R; Gearhart PJ
J Immunol; 1999 Mar; 162(6):3121-4. PubMed ID: 10092760
[TBL] [Abstract][Full Text] [Related]
25. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.
Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B; Gordon M; Reneker J; Arnheim N; Shibata D; Bradley A; Liskay RM
Nat Genet; 1998 Mar; 18(3):276-9. PubMed ID: 9500552
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
[TBL] [Abstract][Full Text] [Related]
27. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair.
Gu L; Hong Y; McCulloch S; Watanabe H; Li GM
Nucleic Acids Res; 1998 Mar; 26(5):1173-8. PubMed ID: 9469823
[TBL] [Abstract][Full Text] [Related]
28. Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.
Baross-Francis A; Makhani N; Liskay RM; Jirik FR
Oncogene; 2001 Feb; 20(5):619-25. PubMed ID: 11313994
[TBL] [Abstract][Full Text] [Related]
29. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
[TBL] [Abstract][Full Text] [Related]
30. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
[TBL] [Abstract][Full Text] [Related]
31. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
33. Expression of DNA mismatch repair genes in naevi.
Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
[TBL] [Abstract][Full Text] [Related]
34. Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow.
Matheson EC; Hall AG
Adv Exp Med Biol; 1999; 457():579-83. PubMed ID: 10500837
[TBL] [Abstract][Full Text] [Related]
35. Effects of sequence divergence on the efficiency of extrachromosomal recombination in mismatch repair proficient and deficient mammalian cell lines.
Villemure JF; Belmaaza A
Somat Cell Mol Genet; 1999 Mar; 25(2):79-90. PubMed ID: 11225058
[TBL] [Abstract][Full Text] [Related]
36. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice.
Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802
[TBL] [Abstract][Full Text] [Related]
37. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
[TBL] [Abstract][Full Text] [Related]
38. Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair.
Tomer G; Buermeyer AB; Nguyen MM; Liskay RM
J Biol Chem; 2002 Jun; 277(24):21801-9. PubMed ID: 11897781
[TBL] [Abstract][Full Text] [Related]
39. Loss of DNA-mismatch repair gene expression in oral melanomas.
Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
[TBL] [Abstract][Full Text] [Related]
40. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
